Fore Biotherapeutics
Biotechnology ResearchPennsylvania, United States51-200 Employees
Fore Biotherapeutics is a biotechnology company based in Philadelphia, Pennsylvania, focused on precision oncology. The firm develops cancer therapies aimed at patients whose tumors carry unaddressed mutations within established oncogenic targets. Grounded in scientific research, it pursues innovative approaches with the aim of advancing solutions for cancer care. The company traces its origins to 2011, reflecting a long-term presence in the field. In the biotechnology research landscape, Fore Biotherapeutics positions itself around targeted oncology development, seeking to fill gaps where current therapies do not address certain mutations. Its work is directed toward clinicians and researchers seeking new treatment options for patients with limited alternatives, addressing unmet needs in cancer treatment. A recent development highlighted at AACR 2025 reported pharmacodynamic activity in tumor biopsies and a reduction in V600E mutant allele frequency in ctDNA among a majority of patients. Based in Philadelphia, the company operates with a mid-sized team and continues to advance its precision oncology program.
1-888-653-2347 
support@leadiq.com 
